Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00295776 · ClinicalTrials.gov registry record · Phase 2
Lamictal in the Treatment of Post-Herpetic Neuralgia
A Phase 2 study, sponsored by George Washington University.
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00295776 is a Phase 2 study that was terminated before completion, run by George Washington University.
The verdict
NCT00295776, a Phase 2 study, was terminated before completion, sponsored by George Washington University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
To assess the efficacy of Lamictal for the treatment of pain and reduction of allodynia in patients with post herpetic neuralgia.
Interventions
- DRUG Lamictal in the treatment of Post-Herpetic Neuralgia
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00295776
The ClinicalTrials.gov registry entry for NCT00295776 describes a study currently listed as terminated, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lamictal in the treatment of Post-Herpetic Neuralgia is the first listed.
NCT00295776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00295776 about?
NCT00295776 is a clinical study titled "Lamictal in the Treatment of Post-Herpetic Neuralgia". To assess the efficacy of Lamictal for the treatment of pain and reduction of allodynia in patients with post herpetic neuralgia.
What is the current status of trial NCT00295776?
This trial is currently terminated. It is a Phase 2 study. The study started on 2005-02.
What interventions are being tested in trial NCT00295776?
The interventions under investigation include: Lamictal in the treatment of Post-Herpetic Neuralgia (DRUG).
Who is sponsoring clinical trial NCT00295776?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.